CSX vs ERNA · P/E 19, rev $14.09B vs P/E 0.0, rev $582.0K
CSX Corporation (CSX) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the CSX and ERNA stock pages for the full models.
Not investment advice.